Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas
- 30 June 1982
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 9, 45-52
- https://doi.org/10.1016/s0305-7372(82)80077-7
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group BCancer, 1980
- A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213Cancer, 1975
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasCancer, 1974
- Epipodophyllotoxin VP 16213 in Treatment of Acute Leukaemia--Haematosarcoma and Solid TumoursBMJ, 1973